Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Closure

PRP.1B -- An Investigation of Molecular and Genetic Risk Factors Associated with Development of Prostate Cancer in Subjects with High Grade Prostatic Intraepithelial Neoplasia Treated with Placebo or Combination Vitamin E, Selenium and Soy Protein Product -- was closed 17 April 2009.